PSTI logo

Pluristem Therapeutics (PSTI) Depreciation And Amortization

Annual D&A

$1.05 M
-$317.00 K-23.14%

01 June 2022

PSTI Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$100.00 K
-$38.00 K-27.54%

01 September 2022

PSTI Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$816.00 K
-$237.00 K-22.51%

01 September 2022

PSTI TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PSTI Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years-23.1%-70.3%-40.0%
5 y5 years-46.3%-78.6%-57.6%

PSTI Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-51.6%-82.6%-63.4%

Pluristem Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2022
-
$100.00 K(-27.5%)
$816.00 K(-22.5%)
June 2022
$1.05 M(-23.1%)
$138.00 K(-45.0%)
$1.05 M(-15.8%)
Mar 2022
-
$251.00 K(-23.2%)
$1.25 M(-6.6%)
Dec 2021
-
$327.00 K(-3.0%)
$1.34 M(-1.5%)
Sept 2021
-
$337.00 K(+0.3%)
$1.36 M(-0.7%)
June 2021
$1.37 M(-12.7%)
$336.00 K(-0.9%)
$1.37 M(-1.3%)
Mar 2021
-
$339.00 K(-2.6%)
$1.39 M(-1.7%)
Dec 2020
-
$348.00 K(+0.3%)
$1.41 M(-2.6%)
Sept 2020
-
$347.00 K(-2.0%)
$1.45 M(-7.7%)
June 2020
$1.57 M(-20.0%)
$354.00 K(-2.5%)
$1.57 M(-7.5%)
Mar 2020
-
$363.00 K(-5.7%)
$1.70 M(-6.4%)
Dec 2019
-
$385.00 K(-17.7%)
$1.81 M(-5.9%)
Sept 2019
-
$468.00 K(-2.7%)
$1.93 M(-1.8%)
June 2019
$1.96 M(-2.8%)
$481.00 K(+0.2%)
$1.96 M(-1.3%)
Mar 2019
-
$480.00 K(-3.6%)
$1.99 M(-0.5%)
Dec 2018
-
$498.00 K(-1.0%)
$2.00 M(-0.5%)
Sept 2018
-
$503.00 K(-0.6%)
$2.01 M(-0.6%)
June 2018
$2.02 M(-7.3%)
$506.00 K(+3.5%)
$2.02 M(-1.2%)
Mar 2018
-
$489.00 K(-3.7%)
$2.04 M(-2.2%)
Dec 2017
-
$508.00 K(-1.4%)
$2.09 M(-2.1%)
Sept 2017
-
$515.00 K(-3.0%)
$2.13 M(-2.0%)
June 2017
$2.18 M(+1.3%)
$531.00 K(-0.9%)
$2.18 M(-1.3%)
Mar 2017
-
$536.00 K(-2.9%)
$2.21 M(-1.0%)
Dec 2016
-
$552.00 K(-1.1%)
$2.23 M(+0.8%)
Sept 2016
-
$558.00 K(-0.4%)
$2.21 M(+2.8%)
June 2016
$2.15 M(+3.7%)
$560.00 K(+0.2%)
$2.15 M(-0.7%)
Mar 2016
-
$559.00 K(+4.7%)
$2.17 M(+3.0%)
Dec 2015
-
$534.00 K(+7.4%)
$2.10 M(+1.4%)
Sept 2015
-
$497.00 K(-13.7%)
$2.07 M(-0.0%)
June 2015
$2.07 M(+9.0%)
$576.00 K(+16.1%)
$2.07 M(+4.5%)
Mar 2015
-
$496.00 K(-1.6%)
$1.98 M(+0.9%)
Dec 2014
-
$504.00 K(+1.2%)
$1.97 M(+1.4%)
Sept 2014
-
$498.00 K(+2.5%)
$1.94 M(+1.9%)
June 2014
$1.90 M(+84.1%)
$486.00 K(+1.5%)
$1.90 M(+2.4%)
Mar 2014
-
$479.00 K(+0.6%)
$1.86 M(+9.6%)
Dec 2013
-
$476.00 K(+3.3%)
$1.69 M(+24.2%)
Sept 2013
-
$461.00 K(+4.5%)
$1.36 M(+32.0%)
June 2013
$1.03 M
$441.00 K(+39.6%)
$1.03 M(+44.5%)
Mar 2013
-
$316.00 K(+116.4%)
$715.00 K(+39.6%)
DateAnnualQuarterlyTTM
Dec 2012
-
$146.00 K(+12.3%)
$512.00 K(+9.4%)
Sept 2012
-
$130.00 K(+5.7%)
$468.00 K(+7.6%)
June 2012
$435.00 K(+39.4%)
$123.00 K(+8.8%)
$435.00 K(+8.8%)
Mar 2012
-
$113.00 K(+10.8%)
$400.00 K(+9.0%)
Dec 2011
-
$102.00 K(+5.2%)
$367.00 K(+8.3%)
Sept 2011
-
$97.00 K(+10.2%)
$339.00 K(+8.7%)
June 2011
$312.00 K(+50.7%)
$88.00 K(+10.0%)
$312.00 K(+10.6%)
Mar 2011
-
$80.00 K(+8.1%)
$282.00 K(+11.0%)
Dec 2010
-
$74.00 K(+5.7%)
$254.00 K(+10.4%)
Sept 2010
-
$70.00 K(+20.7%)
$230.00 K(+11.1%)
June 2010
$207.00 K(+19.7%)
$58.00 K(+11.5%)
$207.00 K(+6.7%)
Mar 2010
-
$52.00 K(+4.0%)
$194.00 K(+4.3%)
Dec 2009
-
$50.00 K(+6.4%)
$186.00 K(+4.5%)
Sept 2009
-
$47.00 K(+4.4%)
$178.00 K(+2.9%)
June 2009
$173.00 K(+34.1%)
$45.00 K(+2.3%)
$173.00 K(+3.0%)
Mar 2009
-
$44.00 K(+4.8%)
$168.00 K(+3.7%)
Dec 2008
-
$42.00 K(0.0%)
$162.00 K(+16.5%)
Sept 2008
-
$42.00 K(+5.0%)
$139.00 K(+7.8%)
June 2008
$129.00 K(-42.6%)
$40.00 K(+5.3%)
$129.00 K(-333.3%)
Mar 2008
-
$38.00 K(+100.0%)
-$55.30 K(-160.3%)
Dec 2007
-
$19.00 K(-40.6%)
$91.70 K(-15.6%)
Sept 2007
-
$32.00 K(-122.2%)
$108.70 K(-51.6%)
June 2007
$224.70 K(-15.1%)
-$144.30 K(-178.0%)
$224.70 K(-54.8%)
Mar 2007
-
$185.00 K(+413.9%)
$497.50 K(+38.9%)
Dec 2006
-
$36.00 K(-75.7%)
$358.30 K(-2.6%)
Sept 2006
-
$148.00 K(+15.2%)
$367.80 K(+38.8%)
June 2006
$264.80 K(+30.5%)
$128.50 K(+180.6%)
$264.90 K(+35.8%)
Mar 2006
-
$45.80 K(+0.7%)
$195.00 K(-6.2%)
Dec 2005
-
$45.50 K(+0.9%)
$207.90 K(+1.2%)
Sept 2005
-
$45.10 K(-23.0%)
$205.50 K(+1.3%)
June 2005
$202.90 K(+32.1%)
$58.60 K(-0.2%)
$202.80 K(-12.2%)
Mar 2005
-
$58.70 K(+36.2%)
$231.00 K(+17.9%)
Dec 2004
-
$43.10 K(+1.7%)
$195.90 K(+12.1%)
Sept 2004
-
$42.40 K(-51.2%)
$174.70 K(+13.7%)
June 2004
$153.60 K(+631.4%)
$86.80 K(+267.8%)
$153.60 K(+129.9%)
Mar 2004
-
$23.60 K(+7.8%)
$66.80 K(+54.6%)
Dec 2003
-
$21.90 K(+2.8%)
$43.20 K(+102.8%)
Sept 2003
-
$21.30 K(-108.1%)
$21.30 K(-108.1%)
June 2003
$21.00 K
-
-
Dec 2001
-
-$264.00 K
-$264.00 K

FAQ

  • What is Pluristem Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Pluristem Therapeutics?
  • What is Pluristem Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Pluristem Therapeutics?
  • What is Pluristem Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Pluristem Therapeutics?

What is Pluristem Therapeutics annual depreciation & amortization?

The current annual D&A of PSTI is $1.05 M

What is the all time high annual D&A for Pluristem Therapeutics?

Pluristem Therapeutics all-time high annual depreciation & amortization is $2.18 M

What is Pluristem Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of PSTI is $100.00 K

What is the all time high quarterly D&A for Pluristem Therapeutics?

Pluristem Therapeutics all-time high quarterly depreciation & amortization is $576.00 K

What is Pluristem Therapeutics TTM depreciation & amortization?

The current TTM D&A of PSTI is $816.00 K

What is the all time high TTM D&A for Pluristem Therapeutics?

Pluristem Therapeutics all-time high TTM depreciation & amortization is $2.23 M